Japanese Drug Company Takeda Pharmaceutical Co With a Stock Market Cap of US$46 Bil Had 30% of Its 2017 Total Revenues Made to US Customers and a Substantially Higher 49% of Its 2017 Total Non-Current Assets Located in the US
From Takeda's 2017 Annual Report
